| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| GILEAD SCIENCES, INC. | 26% | -14% | $427,376,736 | 31,424,760 | 0% | GILEAD SCIENCES, INC. | 03 Nov 2025 | |
| BlackRock, Inc. | 10% | +11% | $303,514,602 | +$65,766,227 | 12,736,927 | +28% | BlackRock, Inc. | 31 Dec 2025 |
| Point72 Asset Management, L.P. | 4.1% | -28% | $58,921,714 | -$20,381,232 | 4,332,479 | -26% | Point72 Asset Management, L.P. | 30 Sep 2025 |
As of 31 Dec 2025, 139 institutional investors reported holding 89,343,889 shares of Arcus Biosciences, Inc. - Common Stock (RCUS). This represents 73% of the company’s total 122,470,452 outstanding shares.
The largest institutional shareholders of Arcus Biosciences, Inc. - Common Stock (RCUS) together control 69% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| GILEAD SCIENCES, INC. | 26% | 31,424,760 | 0% | 39% | $748,852,031 |
| BlackRock, Inc. | 12% | 14,997,891 | +27% | 0.01% | $357,399,743 |
| VANGUARD GROUP INC | 6.5% | 7,962,874 | +20% | 0% | $189,755,288 |
| STATE STREET CORP | 3.7% | 4,576,969 | +35% | 0% | $109,069,171 |
| MARSHALL WACE, LLP | 2.8% | 3,387,794 | 0.08% | $80,731,131 | |
| Siren, L.L.C. | 2.5% | 3,007,077 | +3.3% | 2.1% | $71,658,645 |
| Fisher Asset Management, LLC | 1.6% | 1,949,788 | +167% | 0.02% | $46,463,447 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.6% | 1,907,345 | +19% | 0% | $45,459,101 |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 1.4% | 1,687,374 | +19% | 0.05% | $40,210,000 |
| DIMENSIONAL FUND ADVISORS LP | 1.2% | 1,524,157 | +1.4% | 0.01% | $36,316,719 |
| MORGAN STANLEY | 0.99% | 1,210,754 | -21% | 0% | $28,852,291 |
| GOLDMAN SACHS GROUP INC | 0.95% | 1,168,437 | +23% | 0% | $27,843,854 |
| BARCLAYS PLC | 0.91% | 1,112,258 | +528% | 0.01% | $26,505,110 |
| Sofinnova Investments, Inc. | 0.9% | 1,096,705 | -10% | 1.1% | $26,134,480 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.79% | 968,241 | +11% | 0% | $23,073,183 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 0.76% | 929,981 | -17% | 0.09% | $22,161,447 |
| FRANKLIN RESOURCES INC | 0.7% | 853,491 | 0% | $20,338,691 | |
| Candriam S.C.A. | 0.65% | 790,613 | +109% | 0.09% | $18,841,110 |
| Soleus Capital Management, L.P. | 0.58% | 711,983 | 0.72% | $16,966,555 | |
| First Turn Management, LLC | 0.46% | 565,142 | 1.5% | $13,467,334 | |
| Decheng Capital LLC | 0.44% | 541,559 | -1.1% | 1.7% | $12,905,351 |
| Bank of New York Mellon Corp | 0.41% | 504,462 | +7.3% | 0% | $12,021,338 |
| BNP PARIBAS FINANCIAL MARKETS | 0.35% | 424,071 | 0% | 0.01% | $10,105,612 |
| UBS Group AG | 0.34% | 411,259 | +146% | 0% | $9,800,301 |
| PRINCIPAL FINANCIAL GROUP INC | 0.33% | 407,513 | +22% | 0% | $9,711,035 |
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | 89,343,889 | $2,128,928,276 | +$345,572,310 | $23.83 | 139 |
| 2025 Q3 | 100,610,243 | $1,368,169,306 | +$17,471,089 | $13.60 | 186 |
| 2025 Q2 | 99,735,332 | $811,386,525 | +$23,005,595 | $8.14 | 181 |
| 2025 Q1 | 97,195,653 | $762,981,433 | +$76,941,552 | $7.85 | 183 |
| 2024 Q4 | 83,908,968 | $1,249,338,646 | -$21,214,675 | $14.89 | 185 |
| 2024 Q3 | 53,324,923 | $815,463,718 | +$21,618,657 | $15.29 | 184 |
| 2024 Q2 | 51,955,193 | $791,285,512 | -$15,709,425 | $15.23 | 191 |
| 2024 Q1 | 52,828,671 | $997,275,069 | +$741,376 | $18.88 | 169 |
| 2023 Q4 | 52,818,611 | $1,008,878,346 | -$1,266,933 | $19.10 | 181 |
| 2023 Q3 | 52,811,112 | $947,947,087 | -$30,726,648 | $17.95 | 184 |
| 2023 Q2 | 54,702,646 | $1,110,123,478 | -$11,409,103 | $20.31 | 177 |
| 2023 Q1 | 55,490,875 | $1,012,137,432 | +$17,396,401 | $18.24 | 177 |
| 2022 Q4 | 53,808,832 | $1,112,728,096 | +$17,661,819 | $20.68 | 199 |
| 2022 Q3 | 52,505,739 | $1,373,608,654 | -$54,087 | $26.16 | 171 |
| 2022 Q2 | 52,444,913 | $1,329,092,467 | -$15,970,235 | $25.34 | 162 |
| 2022 Q1 | 50,609,470 | $1,598,261,880 | -$43,817,366 | $31.56 | 146 |
| 2021 Q4 | 50,826,972 | $2,056,609,533 | +$107,109,155 | $40.47 | 136 |
| 2021 Q3 | 48,251,727 | $1,682,950,642 | +$59,932,851 | $34.87 | 127 |
| 2021 Q2 | 45,147,112 | $1,239,729,813 | +$11,589,356 | $27.46 | 125 |
| 2021 Q1 | 44,736,322 | $1,254,917,338 | +$7,899,154 | $28.08 | 143 |
| 2020 Q4 | 44,575,673 | $1,157,187,273 | +$10,417,742 | $25.96 | 143 |
| 2020 Q3 | 44,391,126 | $760,991,949 | +$17,571,170 | $17.14 | 127 |
| 2020 Q2 | 41,840,912 | $1,034,233,021 | +$380,488,277 | $24.74 | 138 |
| 2020 Q1 | 26,992,583 | $374,653,368 | -$448,171 | $13.88 | 92 |
| 2019 Q4 | 23,560,774 | $237,962,351 | -$3,030,738 | $10.10 | 74 |
| 2019 Q3 | 25,809,690 | $234,896,496 | -$672,043 | $9.10 | 73 |
| 2019 Q2 | 26,440,928 | $210,047,107 | +$6,023,856 | $7.95 | 76 |
| 2019 Q1 | 25,799,127 | $322,227,437 | -$12,715,178 | $12.49 | 63 |
| 2018 Q4 | 26,918,679 | $289,911,060 | -$4,742,182 | $10.77 | 66 |
| 2018 Q3 | 22,437,315 | $312,774,356 | +$950,561 | $13.94 | 56 |
| 2018 Q2 | 22,392,855 | $274,091,081 | +$31,576,470 | $12.24 | 61 |
| 2018 Q1 | 16,255,471 | $250,516,107 | +$250,516,106 | $15.44 | 55 |